[ESPR] QoQ Quarter Result on 30-Sep-2000 [#Q3]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
29-Sep-2000
Financial Year
2000
Quarter
30-Sep-2000 [#Q3]
Profit Trend
QoQ- -65.86%
YoY-
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/09/01 30/06/01 31/03/01 31/12/00 30/09/00 30/06/00 31/03/00 CAGR
Revenue 0 1 1 1 1 1 1 -
PBT -6,281 -6,325 -5,981 -6,803 -11,693 -7,371 -5,725 6.36%
Tax 736 -454 -976 1,233 3,556 -308 -376 -
NP -6,281 -6,325 -5,981 -5,565 -10,804 -6,514 -4,693 21.42%
Tax Rate - - - - - - - -
Total Cost 6,281 6,326 5,982 5,566 10,805 6,515 4,694 21.40%
Ratio Analysis
30/09/01 30/06/01 31/03/01 31/12/00 30/09/00 30/06/00 31/03/00 CAGR
NP Margin 0.00 -632,500.00 -598,100.00 -556,500.00 -1,080,400.00 -651,400.00 -469,315.20 -
Per Share
30/09/01 30/06/01 31/03/01 31/12/00 30/09/00 30/06/00 31/03/00 CAGR
EPS -1.56 -1.70 -1.61 -2.65 -5.14 -20.60 -1.95 -13.81%
EPS Diluted -1.56 -1.70 -1.61 -2.65 -5.14 -20.60 -1.95 -13.81%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.